Viyash Scientifi

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE807F01027
  • NSEID: VIYASH
  • BSEID: 512529
INR
257.15
12.8 (5.24%)
BSENSE

Jun 18

BSE+NSE Vol: 31.57 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Part of MojoOne Strategy
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Marksans Pharma
Sanofi Consumer
Akums Drugs
Sudeep Pharma
Viyash Scientifi
Strides Pharma
Alivus Life
Shilpa Medicare
P & G Health Ltd
Concord Biotech
Corona Remedies
Why is Viyash Scientific Ltd ?
1
Weak Long Term Fundamental Strength with a 18.70% CAGR growth in Operating Profits over the last 5 years
  • Low ability to service debt as the company has a high Debt to EBITDA ratio of 9.07 times
  • The company has been able to generate a Return on Equity (avg) of 4.47% signifying low profitability per unit of shareholders funds
2
With a growth in Net Profit of 539.5%, the company declared Outstanding results in Mar 26
  • The company has declared positive results for the last 9 consecutive quarters
  • OPERATING PROFIT TO INTEREST(Q) Highest at 12.69 times
  • PAT(Q) At Rs 52.11 cr has Grown at 446.4%
  • DEBT-EQUITY RATIO(HY) Lowest at 0.17 times
3
Stock is technically in a Bullish range
  • The technical trend has improved from Mildly Bullish on 11-Jun-26 and has generated 1.52% returns since then
  • The stocks MACD and KST technical factors are also Bullish
4
With ROCE of 12.5, it has a Expensive valuation with a 3.5 Enterprise value to Capital Employed
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 30.89%, its profits have risen by 171.8% ; the PEG ratio of the company is 1
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Viyash Scientifi should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Viyash Scientifi for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Viyash Scientifi
32.96%
0.74
41.76%
Sensex
-5.14%
-0.38
13.26%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
17.40%
EBIT Growth (5y)
18.70%
EBIT to Interest (avg)
2.11
Debt to EBITDA (avg)
9.71
Net Debt to Equity (avg)
0.08
Sales to Capital Employed (avg)
1.33
Tax Ratio
37.04%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
10.93%
ROCE (avg)
5.79%
ROE (avg)
4.47%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
56
Industry P/E
34
Price to Book Value
3.67
EV to EBIT
27.82
EV to EBITDA
18.64
EV to Capital Employed
3.48
EV to Sales
3.55
PEG Ratio
1.01
Dividend Yield
NA
ROCE (Latest)
12.52%
ROE (Latest)
6.50%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

37What is working for the Company
OPERATING PROFIT TO INTEREST(Q)

Highest at 12.69 times

PAT(Q)

At Rs 52.11 cr has Grown at 446.4%

DEBT-EQUITY RATIO(HY)

Lowest at 0.17 times

NET SALES(Q)

Highest at Rs 919.96 cr

PBDIT(Q)

Highest at Rs 184.25 cr.

PBT LESS OI(Q)

Highest at Rs 109.32 cr.

CASH AND CASH EQUIVALENTS(HY)

Highest at Rs 269.71 cr

-3What is not working for the Company
DEBTORS TURNOVER RATIO(HY)

Lowest at 2.94 times

Loading Valuation Snapshot...
Here's what is working for Viyash Scientifi
Net Sales - Quarterly
At Rs 919.96 cr has Grown at 129.02%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very positive

Net Sales (Rs Cr)

Operating Profit to Interest - Quarterly
Highest at 12.69 times and Grown
each quarter in the last five quarters
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 109.32 cr has Grown at 629.29%
Year on Year (YoY)
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 52.11 cr has Grown at 446.4%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Net Sales - Quarterly
Highest at Rs 919.96 cr and Grown
each quarter in the last five quarters
MOJO Watch
Near term sales trend is very positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 184.25 cr. and Grown
each quarter in the last five quarters
MOJO Watch
Near term Operating Profit trend is quite positive

Operating Profit (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 109.32 cr. and Grown
each quarter in the last five quarters
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Debt-Equity Ratio - Half Yearly
Lowest at 0.17 times and Fallen
each half year in the last five half yearly periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Cash and Cash Equivalents - Half Yearly
Highest at Rs 269.71 cr
in the last six half yearly periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Here's what is not working for Viyash Scientifi
Debtors Turnover Ratio- Half Yearly
Lowest at 2.94 times
in the last five half yearly periods
MOJO Watch
Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio

Non Operating Income - Quarterly
Highest at Rs 15.92 cr
in the last five quarters
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating Income